Diagnosis, toxicological mechanism, and detoxification for hepatotoxicity induced by pyrrolizidine alkaloids from herbal medicines or other plants
- 7 February 2024
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 54 (2) , 123-133
Abstract
Pyrrolizidine alkaloids (PAs) are one type of phytotoxins distributed in various plants, including many medicinal herbs. Many organs might suffer injuries from the intake of PAs, and the liver is the most susceptible one. The diagnosis, toxicological mechanism, and detoxification of PAs-induced hepatotoxicity have been studied for several decades, which is of great significance for its prevention, diagnosis, and therapy. When the liver was exposed to PAs, liver sinusoidal endothelial cells (LSECs) loss, hemorrhage, liver parenchymal cells death, nodular regeneration, Kupffer cells activation, and fibrogenesis occurred. These pathological changes classified the PAs-induced liver injury as acute, sub-acute, and chronic type. PAs metabolic activation, mitochondria injury, glutathione (GSH) depletion, inflammation, and LSECs damage-induced activation of the coagulation system were well recognized to play critical roles in the pathological process of PAs-induced hepatotoxicity. A lot of natural compounds like glycyrrhizic acid, (-)-epicatechin, quercetin, baicalein, chlorogenic acid, and so on were demonstrated to be effective in alleviating PAs-induced liver injury, which rendered them huge potential to be developed into therapeutic drugs for PAs poisoning in clinics. This review presents updated information about the diagnosis, toxicological mechanism, and detoxification studies on PAs-induced hepatotoxicity.Keywords
Funding Information
- Young Qihuang Scholar
- Program of Shanghai Academic Research Leader
- National Natural Science Foundation of China
- Shanghai Pujiang Program
This publication has 98 references indexed in Scilit:
- Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria‐mediated apoptosisJournal of Applied Toxicology, 2020
- Tissue factor antisense deoxyoligonucleotide prevents monocrotaline/LPS hepatotoxicity in miceJournal of Applied Toxicology, 2012
- Protective mechanisms ofN‐acetyl‐cysteine against pyrrolizidine alkaloid clivorine‐induced hepatotoxicityJournal of Cellular Biochemistry, 2009
- Vascular disorders of the liver # †Hepatology, 2009
- Decreased Hepatic Nitric Oxide Production Contributes to the Development of Rat Sinusoidal Obstruction SyndromeHepatology, 2003
- Anticoagulants Prevent Monocrotaline-Induced Hepatic Parenchymal Cell Injury but Not Endothelial Cell Injury in the RatToxicology and Applied Pharmacology, 2002
- Induction of Cytochrome P450 Enzymes in the Livers of Rats Treated with the Pyrrolizidine Alkaloid RetrorsineExperimental and Molecular Pathology, 2000
- Synergistic Hepatotoxicity from Coexposure to Bacterial Endotoxin and the Pyrrolizidine Alkaloid MonocrotalineToxicology and Applied Pharmacology, 2000
- Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the ratHepatology, 2000
- Characterization of A Reproducible Rat Model of Hepatic Veno–Occlusive DiseaseHepatology, 1999